Shares of Sunshine Biopharma, Inc. (SBFM) are falling more than 48 percent on Wednesday morning trade, continuing a bearish trend since it announced a one-for-one hundred reverse stock split. The stock split is effective from today and is intended to regain compliance with Nasdaq's minimum bid price requirement for continued listing.
Currently, shares are at $3.51, down 48.52 percent from the previous close of $6.80 on a volume of 2,086,248.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.